The invention provides methods for reducing undesired immune responses such as anti- drug antibody (ADA) responses and other T- and/or B-cell-mediated immune responses in patients by using treatment with methotrexate.

The invention provides methods for reducing undesired immune responses such as anti- drug antibody (ADA) responses and other T- and/or B-cell-mediated immune responses in patients by using treatment with methotrexate.

A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula: and sa...

This invention relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof to a patient in need of such treatment. The invention further relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt, hydrate, solvate, clathrate, prodrug or metabolite thereof a...

This invention relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt hydrate solvate clathrate prodrug or metabolite thereof to a patient in need of such treatment. The invention further relates to methods of treating or preventing an autoimmune disorder comprising the administration of clofarabine or a pharmaceutically acceptable salt hydrate solvate clathrate prodrug or metabolite thereof and an ad...

The present invention provides tablets containing at least about 70% of polystyrene sulfonate polymer binder and moisture. The invention further relates to methods of treating medical conditions including antibiotic-associated diarrhea such as that caused by Chlostridium difficile comprising administration of the tablets to a subject in need thereof. Furthermore pharmaceutical blends and methods of preparing the tablets are disclosed.

Uso de cloruro de hidrógeno de sevelámero para la fabricación de un medicamento para el fin de reducir la glucosa en suero en un individuo que lo necesita.